A Markov model of fibrosis development in nonalcoholic fatty liver disease predicts fibrosis progression in clinical cohorts.

Saved in:
Bibliographic Details
Title: A Markov model of fibrosis development in nonalcoholic fatty liver disease predicts fibrosis progression in clinical cohorts.
Authors: Knöchel, Jane1 (AUTHOR) jane.knochel@astrazeneca.com, Bergenholm, Linnéa2 (AUTHOR), Ibrahim, Eman3 (AUTHOR), Kechagias, Stergios4 (AUTHOR), Hansson, Sara5 (AUTHOR), Liljeblad, Mathias5 (AUTHOR), Nasr, Patrik4 (AUTHOR), Carlsson, Björn5 (AUTHOR), Ekstedt, Mattias4 (AUTHOR), Ueckert, Sebastian1 (AUTHOR)
Source: CPT: Pharmacometrics & Systems Pharmacology. Dec2023, Vol. 12 Issue 12, p2038-2049. 12p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
Description
ISSN:21638306
DOI:10.1002/psp4.13052